Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| astrocyte | 5 studies | 30% ± 12% | |
| oligodendrocyte | 4 studies | 22% ± 4% | |
| endothelial cell | 3 studies | 25% ± 9% | |
| GABAergic neuron | 3 studies | 38% ± 13% | |
| glutamatergic neuron | 3 studies | 40% ± 12% | |
| interneuron | 3 studies | 42% ± 20% | |
| oligodendrocyte precursor cell | 3 studies | 33% ± 9% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| brain | 5 studies | 28% ± 10% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| prostate | 100% | 1160.64 | 245 / 245 | 100% | 9.58 | 501 / 502 |
| brain | 100% | 995.60 | 2639 / 2642 | 100% | 13.15 | 704 / 705 |
| thymus | 100% | 1521.53 | 653 / 653 | 100% | 10.48 | 603 / 605 |
| breast | 100% | 1138.49 | 459 / 459 | 99% | 12.04 | 1112 / 1118 |
| lung | 100% | 904.39 | 577 / 578 | 99% | 6.45 | 1140 / 1155 |
| pancreas | 99% | 607.74 | 325 / 328 | 99% | 7.18 | 177 / 178 |
| bladder | 100% | 1233.71 | 21 / 21 | 98% | 6.96 | 495 / 504 |
| uterus | 100% | 1264.14 | 170 / 170 | 98% | 7.17 | 450 / 459 |
| esophagus | 100% | 958.37 | 1445 / 1445 | 98% | 6.72 | 179 / 183 |
| adrenal gland | 100% | 989.76 | 258 / 258 | 97% | 6.70 | 224 / 230 |
| ovary | 100% | 1342.22 | 180 / 180 | 97% | 5.89 | 418 / 430 |
| intestine | 100% | 1088.86 | 966 / 966 | 97% | 6.54 | 512 / 527 |
| skin | 100% | 1087.45 | 1808 / 1809 | 97% | 11.81 | 456 / 472 |
| stomach | 100% | 755.28 | 359 / 359 | 96% | 6.63 | 275 / 286 |
| kidney | 100% | 756.97 | 89 / 89 | 96% | 5.89 | 864 / 901 |
| liver | 100% | 568.15 | 226 / 226 | 91% | 4.28 | 369 / 406 |
| adipose | 100% | 1104.58 | 1204 / 1204 | 0% | 0 | 0 / 0 |
| blood vessel | 100% | 1015.95 | 1335 / 1335 | 0% | 0 | 0 / 0 |
| muscle | 100% | 1129.47 | 803 / 803 | 0% | 0 | 0 / 0 |
| spleen | 100% | 888.92 | 241 / 241 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 100% | 2.30 | 1 / 1 |
| tonsil | 0% | 0 | 0 / 0 | 98% | 5.27 | 44 / 45 |
| heart | 98% | 624.20 | 840 / 861 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 97% | 5.51 | 28 / 29 |
| eye | 0% | 0 | 0 / 0 | 78% | 6.31 | 62 / 80 |
| peripheral blood | 59% | 427.73 | 544 / 929 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_0045944 | Biological process | positive regulation of transcription by RNA polymerase II |
| GO_0006357 | Biological process | regulation of transcription by RNA polymerase II |
| GO_0005634 | Cellular component | nucleus |
| GO_0000978 | Molecular function | RNA polymerase II cis-regulatory region sequence-specific DNA binding |
| GO_0001228 | Molecular function | DNA-binding transcription activator activity, RNA polymerase II-specific |
| GO_0046872 | Molecular function | metal ion binding |
| Gene name | ZNF197 |
| Protein name | ZNF197 protein Zinc finger protein 197 Zinc finger protein 197 (Zinc finger protein with KRAB and SCAN domains 9) (ZnF20) (pVHL-associated KRAB domain-containing protein) |
| Synonyms | ZKSCAN9 ZNF166 |
| Description | FUNCTION: May be involved in transcriptional regulation. |
| Accessions | Q4G1C8 ENST00000627517.2 [O14709-2] ENST00000627845.1 [O14709-1] ENST00000627004 ENST00000334075.6 ENST00000383744.8 [O14709-2] ENST00000627752.2 [O14709-2] C9JQH5 F8WEU5 ENST00000383745.6 [O14709-2] ENST00000628172.3 [O14709-1] ENST00000412641.1 O14709 ENST00000627858 ENST00000396058.1 [O14709-1] ENST00000344387.9 [O14709-1] |
